WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011011927) USE OF RNF13 PROTEIN AND ENCODING GENE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR PREVENTING AND/OR TREATING MENTAL COGNITIVE DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/011927    International Application No.:    PCT/CN2009/073031
Publication Date: 03.02.2011 International Filing Date: 31.07.2009
IPC:
A61K 38/12 (2006.01), A61K 48/00 (2006.01), A61P 25/14 (2006.01), A61P 25/16 (2006.01), A61P 25/28 (2006.01)
Applicants: INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES [CN/CN]; No. 5,Dongdan San Tiao Dongcheng District Beijing 100005 (CN) (For All Designated States Except US).
ZHU, Dahai [CN/CN]; (CN) (For US Only).
LI, Yanfeng [CN/CN]; (CN) (For US Only).
ZHANG, Qiang [CN/CN]; (CN) (For US Only).
ZHANG, Lei [CN/CN]; (CN) (For US Only).
YANG, Nan [CN/CN]; (CN) (For US Only).
JIN, Xianglan [CN/CN]; (CN) (For US Only).
MENG, Jiao [CN/CN]; (CN) (For US Only)
Inventors: ZHU, Dahai; (CN).
LI, Yanfeng; (CN).
ZHANG, Qiang; (CN).
ZHANG, Lei; (CN).
YANG, Nan; (CN).
JIN, Xianglan; (CN).
MENG, Jiao; (CN)
Agent: GE CHENG & CO., LTD.; Level 19, Tower E3, The Towers, Oriental Plaza No.1, East Chang An Avenue, Dongcheng District Beijing 100738 (CN)
Priority Data:
Title (EN) USE OF RNF13 PROTEIN AND ENCODING GENE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR PREVENTING AND/OR TREATING MENTAL COGNITIVE DISORDERS
(FR) UTILISATION DE LA PROTÉINE RNF13 ET DU GÈNE CODANT DE CELLE-CI DANS L'ÉLABORATION DE MÉDICAMENTS DESTINÉS À PRÉVENIR ET/OU À TRAITER DES TROUBLES MENTAUX COGNITIFS
(ZH) RNF13蛋白及其编码基因在制备预防和/或治疗精神认知障碍疾病的药物中的用途
Abstract: front page image
(EN)The present invention relates to the use of RNF13 protein and encoding gene thereof in the preparation of medicaments for preventing and/or treating mental cognitive disorders. The present invention further relates to the use of RNF13 gene knockout mice in screening medicaments for preventing and/or treating mental cognitive disorders.
(FR)L'invention concerne l'utilisation de la protéine RNF13 et du gène codant de celle-ci dans l'élaboration de médicaments destinés à prévenir et/ou à traiter des troubles mentaux cognitifs. L'invention concerne de plus l'utilisation de souris knockout du gène RNF13 dans le criblage de médicaments destinés à prévenir et/ou à traiter des troubles mentaux cognitifs.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)